Monthly Archives: August 2009

H1N1 Vaccine Quantities to Fall Short of Predictions

By George Koroneos | Published: August 19, 2009
Image by â– Guerry via Flickr The US may not have as many H1N1 flu vaccines available from the get-go as originally anticipated, CBS News reported on Tuesday. According to the report, approximately 45 million doses will be available in mid-October—that’s down from the original plan of 120 million doses. The new plan calls for [...]
Posted in Manufacturing | Tagged , , , , , , | 2 Comments

Lilly Osteoporosis Drug Canned in Phase III Trials

By George Koroneos | Published: August 19, 2009
Image by go elsewhere… via Flickr Lilly, on Wednesday, announced that it would not seek regulatory approval for its osteoporosis treatment arzoxifene, because the drug failed to meet certain end points in Phase III clinical trials. The good news is that the drug was successful in meeting the primary end point of the trial, dubbed “GENERATIONS.” [...]
Posted in Strategy | Tagged , , , , , , | 1 Comment

Tauzin to Boehner: Don’t “Bully” Me

By Walter Armstrong | Published: August 19, 2009
Image via Wikipedia PhRMA chief Billy Tauzin so far shows no sign of waving the white flag in response to an accusatory missive from House Minority Leader Rep. John Boehner bludgeoning his former Republican colleague for leading the drug industry’s support of President Obama’s healthcare reform effort. Pointedly CC’d to pharma CEOs – Tauzin’s employers—and simultaneously [...]
Posted in Regulatory | Tagged , , , , , , , | Leave a comment

The UK NHS is Many Things. Evil isn’t One of Them.

By Julian Upton | Published: August 17, 2009
Far be it from me to politicize this blog, but I have great trouble understanding how anyone can brand a system based on the principles of providing healthcare for all as ‘evil’.  The UK NHS has many flaws. It is over-stretched, weary, beleaguered, underfunded, occasionally incompetent, occasionally misguided, in parts outmoded, over-managed and often frustrating. But [...]
Posted in Global, Regulatory | Tagged , , , , , | 1 Comment

Woodcock Under Investigation

By George Koroneos | Published: August 12, 2009
Image by Getty Images via Daylife An FDA director has come under fire by a generics firm claiming that the director of the Center for Drug Evaluation and Research favored a competitor in a wanton act of conflict of interest. The Wall Street Journal this morning broke the story that Janet Woodcock is under investigation by [...]
Posted in Strategy | Tagged , , , , , , | Leave a comment